PATENT CLAIM ANALYSIS

Application Number: 16172573
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["424", "465000"]

Abstract:
Provided are solid dispersions of Compound I having the formula: wherein Compound I is substantially amorphous, methods of manufacturing said solid dispersions, and methods of using said solid dispersions.

Claim (Index 42):
The method according to  claim 41 , wherein the CYP3A inhibitor is boceprevir, cobicistat, conivaptan, danoprevir and ritonavir, elvitegravir and ritonavir, grapefruit juice, indinavir and ritonavir, itraconazole, ketoconazole, lopinavir and ritonavir, posaconazole, ritonavir, saquinavir and ritonavir, telaprevir, tipranavir and ritonavir, troleandomycin, voriconazole, clarithromycin, diltiazem, idelalisib, nefazodone, nelfinavir, or paritaprevir and ritonavir and ombitasvir and/or dasabuvir.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 97.0
- Lexical Diversity: 1.5
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15128714', '13843224', '12934296', '13183119', '16035771']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7235010937738213
- 35 USC 102 Novelty (BERT): 0.5044827533873758
- Combined Prediction Score: 0.7015992597351768
- Mean Citation Score: 162.41165800000005
- Max Citation Score: 169.05733
- Similarity Product: 99.81108158532145

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test